Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 253

1.

Sex differences in performance of fecal occult blood testing.

Brenner H, Haug U, Hundt S.

Am J Gastroenterol. 2010 Nov;105(11):2457-64. doi: 10.1038/ajg.2010.301. Epub 2010 Aug 10.

PMID:
20700114
[PubMed - indexed for MEDLINE]
2.

Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.

Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, Han DS.

Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25.

PMID:
20502450
[PubMed - indexed for MEDLINE]
3.

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

Hundt S, Haug U, Brenner H.

Ann Intern Med. 2009 Feb 3;150(3):162-9.

PMID:
19189905
[PubMed - indexed for MEDLINE]
4.

Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany.

Brenner H, Hoffmeister M, Birkner B, Stock C.

Am J Gastroenterol. 2014 Mar;109(3):427-35. doi: 10.1038/ajg.2013.424. Epub 2013 Dec 17.

PMID:
24343548
[PubMed - indexed for MEDLINE]
5.

Performance improvements of stool-based screening tests.

van Dam L, Kuipers EJ, van Leerdam ME.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):479-92. doi: 10.1016/j.bpg.2010.03.009. Review.

PMID:
20833351
[PubMed - indexed for MEDLINE]
6.

Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction.

Roslani AC, Abdullah T, Arumugam K.

Asian Pac J Cancer Prev. 2012;13(1):237-41.

PMID:
22502676
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.

Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S, Coupe VM, Berkhof J, Bouman AA, Meijer GA, Mulder CJ.

Aliment Pharmacol Ther. 2010 Feb 1;31(3):432-9. doi: 10.1111/j.1365-2036.2009.04184.x. Epub 2009 Oct 29.

PMID:
19878150
[PubMed - indexed for MEDLINE]
9.

Summaries for patients. Immunochemical fecal occult blood tests.

[No authors listed]

Ann Intern Med. 2009 Feb 3;150(3):I34. No abstract available.

PMID:
19189901
[PubMed - indexed for MEDLINE]
10.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

PMID:
17895475
[PubMed - indexed for MEDLINE]
Free Article
11.

Stool test for colorectal cancer screening--it's time to move!

Loitsch SM, Shastri Y, Stein J.

Clin Lab. 2008;54(11-12):473-84. Review.

PMID:
19216253
[PubMed - indexed for MEDLINE]
12.

Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.

Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.

Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.

PMID:
22108194
[PubMed - indexed for MEDLINE]
13.

Fecal occult blood testing.

Sanford KW, McPherson RA.

Clin Lab Med. 2009 Sep;29(3):523-41. doi: 10.1016/j.cll.2009.06.008.

PMID:
19840685
[PubMed - indexed for MEDLINE]
14.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
[PubMed - indexed for MEDLINE]
15.

Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme.

Kearns B, Whyte S, Chilcott J, Patnick J.

Br J Cancer. 2014 Oct 28;111(9):1734-41. doi: 10.1038/bjc.2014.469. Epub 2014 Sep 2.

PMID:
25180767
[PubMed - indexed for MEDLINE]
16.

Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.

Fraser CG, Digby J, McDonald PJ, Strachan JA, Carey FA, Steele RJ.

J Med Screen. 2012 Mar;19(1):8-13. doi: 10.1258/jms.2011.011098. Epub 2011 Dec 7.

PMID:
22156144
[PubMed - indexed for MEDLINE]
17.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
[PubMed - indexed for MEDLINE]
18.

Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.

Ko CW, Dominitz JA, Nguyen TD.

Am J Med. 2003 Aug 1;115(2):111-4.

PMID:
12893396
[PubMed - indexed for MEDLINE]
19.

A combination of serum markers for the early detection of colorectal cancer.

Wild N, Andres H, Rollinger W, Krause F, Dilba P, Tacke M, Karl J.

Clin Cancer Res. 2010 Dec 15;16(24):6111-21. doi: 10.1158/1078-0432.CCR-10-0119. Epub 2010 Aug 26.

PMID:
20798228
[PubMed - indexed for MEDLINE]
Free Article
20.

Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.

Brenner H, Hoffmeister M, Birkner B, Stock C.

Int J Cancer. 2014 Jun 15;134(12):2927-34. doi: 10.1002/ijc.28618. Epub 2013 Dec 11.

PMID:
24374771
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk